| Jumlah Saham Beredar | 3,203,310 shares |
| Saham Orang Dalam | 837,429 shares |
| Kepemilikan oleh Orang Dalam | 26.14 % |
| Orang Dalam Sejati | 25 |
Skor Sentimen Orang Dalam
Skor Sentimen Orang Dalam mengidentifikasi perusahaan yang dibeli oleh orang dalam korporat.
Ini adalah hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi internal tertinggi. Model penilaian ini menggunakan kombinasi dari jumlah bersih orang dalam yang membeli dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase dari jumlah saham yang beredar, dan total saham yang dimiliki oleh orang dalam. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi dibandingkan dengan perusahaan sejenis, dan 50 adalah rata-rata.
Frekuensi Pembaruan: Setiap Hari
Skor Sentimen Petugas
Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Korporat.
Menurut definisi, Pejabat Korporasi adalah Orang Dalam Korporasi, tetapi tidak seperti beberapa Orang Dalam lainnya (Pemegang Saham 10% dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat bertransaksi . (Pemegang Saham 10% dan Anggota Dewan seringkali adalah manajer dana yang mengelola uang orang lain.) Dengan demikian, transaksi orang dalam yang dilakukan oleh Pejabat jauh lebih signifikan dan harus ditangani dengan tepat.
Seperti Skor Sentimen Internal, Skor Sentimen Pejabat adalah hasil dari model kuantitatif multi-faktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.
Frekuensi Pembaruan: Setiap Hari
Metrik Utama Orang Dalam
Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik internal. Peringkat persentil menunjukkan bagaimana perusahaan ini dibandingkan dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.
Sebagai contoh, secara umum diterima bahwa pembelian oleh orang dalam perusahaan adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian oleh orang dalam akan mendapat peringkat lebih tinggi daripada perusahaan dengan lebih sedikit pembelian oleh orang dalam (atau bahkan penjualan oleh orang dalam).
Jumlah Bersih Pembelian oleh Orang Dalam (Peringkat)
0 ( )
4898 out of 11305Jumlah Bersih Pembelian oleh Orang Dalam adalah total jumlah orang dalam yang membeli dikurangi total jumlah orang dalam yang menjual dalam 90 hari terakhir. Peringkat persentil ditunjukkan di sini (kisaran dari 0 hingga 100%).
Persentase Saham yang Dibeli oleh Orang Dalam (Peringkat)
0.000 %( )
4875 out of 11224Persentase Saham yang Dibeli oleh Orang Dalam adalah total jumlah saham yang dibeli oleh orang dalam dikurangi total jumlah saham yang dijual oleh orang dalam dalam 90 hari terakhir, dibagi dengan total jumlah saham yang beredar dan dikalikan dengan 100.
Grafik Perdagangan Orang Dalam
Grafik berikut menunjukkan Cyclerion Therapeutics, Inc. transaksi orang dalam. Orang dalam adalah pejabat, direktur, atau investor signifikan dalam suatu perusahaan. Secara umum, melakukan transaksi di perusahaan mereka berdasarkan informasi material yang belum dipublikasikan adalah ilegal bagi orang dalam. Ini tidak berarti bahwa mereka dilarang melakukan transaksi apa pun di perusahaan mereka sendiri. Namun, mereka wajib melaporkan semua transaksi kepada SEC melalui Formulir 4.
Daftar Orang Dalam dan Metrik Profitabilitas
Tabel ini menampilkan daftar orang dalam yang diketahui, dan dibuat secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan sebutan direktur, pejabat, atau pemilik 10%, kami memberikan kepemilikan terbaru yang diungkapkan. Selain itu, jika memungkinkan, kami memberikan kinerja perdagangan historis untuk orang dalam tersebut. Kinerja perdagangan historis adalah rata-rata tertimbang dari kinerja transaksi pembelian pasar terbuka aktual yang dilakukan oleh orang dalam tersebut. Untuk informasi lebih lanjut tentang bagaimana ini dihitung, tonton webinar YouTube ini.
See our leaderboard of most profitable insider traders.
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|---|---|---|
| Andreas Busch Chief Innovation Officer - [O] | 254,704 | 12,735 | |
| Chicko Rhonda M. Chief Financial Officer - [O] | 18 | 18 | |
| George H Conrades Director - [D] | 4,334 | 217 | |
| Kevin Churchwell Director - [D] | 2,421 | 121 | |
| Gina Consylman | 0 | ||
| Mark G Currie President and CSO - [O] | 251,648 | 12,582 | |
| Errol B Desouza Director - [D] | 30,000 | 30,000 | |
| Marsha Fanucci Director - [D] | 16,950 | 848 |
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|---|---|---|
| Cheryl Gault Chief Operating Officer - [O] | 794 | 40 | |
| Anjeza Gjino Chief Financial Officer - [O] | 31,599 | 1,580 | |
| Regina Margaret Graul President - [O] | 100,303 | 100,303 | |
|
David Gerald Greenspan
10% Owner -
|
7,157,601 | 0 | |
|
Peter M Hecht
Director, 10% Owner -
[D]
|
559,275 | 559,275 | |
| Michael J Higgins Director - [D] | 30,740 | 30,740 | |
| William Huyett Chief Financial Officer - [O] | 67,590 | 3,380 | |
| Steven Hyman Director - [D] | 20,000 | 20,000 |
| Orang Dalam | Rata-rata Keuntungan (%) | Saham Dimiliki |
Terbagi Disesuaikan |
|---|---|---|---|
|
Ironwood Pharmaceuticals Inc
10% Owner -
|
0 | 0 | |
| Ole Isacson Director - [D] | 2,421 | 121 | |
| Dina Katabi Director - [D] | 20,000 | 20,000 | |
| Stephanie Lovell Director - [D] | 2,421 | 121 | |
| Terrance Mcguire Director - [D] | 42,010 | 42,010 | |
| Michael Mendelsohn Director - [D] | 2,421 | 121 | |
| Amy W Schulman Director - [D] | 21,635 | 1,082 | |
|
Slate Path Capital LP
10% Owner -
|
0 | 0 | |
| Christopher I Wright Chief Medical Officer - [O] | 42,728 | 2,136 |
Report errors via our new Insider Auditing Tool
Rekam Jejak Pembelian Orang Dalam - Analisis Keuntungan Jangka Pendek
Pada bagian ini, kami menganalisis profitabilitas setiap pembelian saham oleh orang dalam di pasar terbuka yang tidak direncanakan yang dilakukan di CYCN / Cyclerion Therapeutics, Inc.. Analisis ini membantu memahami apakah orang dalam tersebut secara konsisten menghasilkan pengembalian abnormal, dan layak untuk diikuti. Analisis ini dilakukan selama satu tahun setelah setiap transaksi, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan pembelian pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Rekam Jejak Penjualan Orang Dalam - Analisis Kerugian Jangka Pendek
Dalam bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan dalam pasar terbuka yang tidak direncanakan oleh orang dalam yang dilakukan di CYCN / Cyclerion Therapeutics, Inc.. Pola penghindaran kerugian yang konsisten dapat menunjukkan bahwa transaksi penjualan di masa mendatang dapat memprediksi penurunan harga. Analisis ini berlaku untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoretis .
Tabel berikut menunjukkan penjualan pasar terbuka terbaru yang bukan bagian dari rencana perdagangan otomatis.
Harga yang Disesuaikan adalah harga yang disesuaikan dengan pemisahan saham. Ang Adjusted Shares ay ang jumlah saham yang disesuaikan dengan pemisahan saham (stock split).
Riwayat Transaksi
Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan memiliki tanda X di kolom yang bertanda 10b-5.
| Berkas Tanggal |
Perdagangan Tanggal |
Formulir | Orang Dalam | Ticker | Judul Keamanan | Kode | Langsung | Latihan Harga |
Satuan Harga |
Unit Diubah |
Nilai Diubah (1 ribu) |
Sisa Pilihan |
Sisa Saham |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-27 | 2025-03-25 | 4 | Hecht Peter M | CYCN | Common Stock | D | 2.7500 | 181,818 | 500 | 559,203 | ||||
| 2025-03-27 | 2025-03-25 | 4 | Higgins Michael J | CYCN | Common Stock | D | 2.7500 | 9,090 | 25 | 30,740 | ||||
| 2024-11-25 | 2024-11-21 | 4 | Slate Path Capital LP | CYCN | Common Stock, no par value | I | 1.5511 | -357,880 | -555 | 0 | ||||
| 2024-03-11 | 3 | CHICKO RHONDA M. | CYCN | Common Stock | D | 18 | ||||||||
| 2024-01-26 | 2024-01-01 | 4 | Hecht Peter M | CYCN | Common Stock | D | 15,000 | 377,385 | ||||||
| 2024-01-26 | 2024-01-01 | 4 | Graul Regina Margaret | CYCN | Common Stock | D | 50,000 | 100,303 | ||||||
| 2023-12-11 | 3 | Katabi Dina | CYCN | Common Stock | D | 20,000 | ||||||||
| 2023-12-07 | 3/A | Graul Regina Margaret | CYCN | Common Stock | D | 50,303 | ||||||||
| 2023-12-07 | 3 | Higgins Michael J | CYCN | Common Stock | D | 21,650 | ||||||||
| 2023-12-04 | 2023-11-30 | 4 | DESOUZA ERROL B | CYCN | Common Stock | D | 30,000 | 30,000 | ||||||
| 2023-12-04 | 2023-11-30 | 4 | DESOUZA ERROL B | CYCN | Common Stock | D | 20,000 | 50,000 | ||||||
| 2023-12-04 | 2023-12-01 | 4 | Hecht Peter M | CYCN | Common Stock | D | 15,000 | 362,385 | ||||||
| 2023-12-04 | 2023-11-30 | 4 | Hecht Peter M | CYCN | Common Stock | D | 20,000 | 347,385 | ||||||
| 2023-12-04 | 2023-11-30 | 4 | MCGUIRE TERRANCE | CYCN | Common Stock | D | 5,000 | 5,552 | ||||||
| 2023-12-04 | 3 | Graul Regina Margaret | CYCN | Common Stock | D | 50,000 | ||||||||
| 2023-12-04 | 2023-11-30 | 4 | Hyman Steven | CYCN | Common Stock | D | 20,000 | 20,000 | ||||||
| 2023-08-11 | 2023-08-09 | 4 | MCGUIRE TERRANCE By Polaris Venture Management Co. II, L.L.C. | CYCN | Common Stock | I | 3.3950 | -8 | -0 | 0 | ||||
| 2023-05-22 | 2023-05-19 | 4 | Hecht Peter M | CYCN | Common Stock | D | 8.6800 | 225,000 | 1,953 | 327,385 | ||||
| 2022-07-26 | 3 | Hyman Steven | CYCN | Common Stock | D | 0 | ||||||||
| 2022-01-24 | 2022-01-20 | 4 | Busch Andreas | CYCN | Employee Stock Option (Right to Buy) | D | 1.21 | 135,000 | 135,000 | |||||
| 2022-01-24 | 2022-01-20 | 4 | Gjino Anjeza | CYCN | Employee Stock Option (Right to Buy) | D | 1.21 | 135,000 | 135,000 | |||||
| 2022-01-24 | 2022-01-20 | 4 | Hecht Peter M | CYCN | Employee Stock Option (Right to Buy) | D | 1.21 | 430,000 | 430,000 | |||||
| 2022-01-24 | 2022-01-03 | 4 | Hecht Peter M | CYCN | Employee Stock Option (Right to Buy) | D | 1.78 | 52,950 | 52,950 | |||||
| 2022-01-24 | 2022-01-20 | 4 | Gault Cheryl | CYCN | Employee Stock Option (Right to Buy) | D | 1.21 | 135,000 | 135,000 | |||||
| 2021-12-10 | 2021-12-09 | 4 | Gault Cheryl | CYCN | Employee Stock Option (Right to Buy) | D | 1.93 | 100,000 | 100,000 | |||||
| 2021-12-10 | 2021-12-09 | 4 | Gjino Anjeza | CYCN | Employee Stock Option (Right to Buy) | D | 1.93 | 100,000 | 100,000 | |||||
| 2021-12-10 | 2021-12-09 | 4 | Busch Andreas | CYCN | Employee Stock Option (Right to Buy) | D | 1.93 | 75,000 | 75,000 | |||||
| 2021-06-28 | 2021-06-24 | 4 | Lovell Stephanie | CYCN | Stock Option (Right to Buy) | D | 3.97 | 10,000 | 10,000 | |||||
| 2021-06-28 | 2021-06-24 | 4 | Fanucci Marsha | CYCN | Stock Option (Right to Buy) | D | 3.97 | 10,000 | 10,000 | |||||
| 2021-06-28 | 2021-06-24 | 4 | Isacson Ole | CYCN | Stock Option (Right to Buy) | D | 3.97 | 10,000 | 10,000 | |||||
| 2021-06-28 | 2021-06-24 | 4 | Churchwell Kevin | CYCN | Stock Option (Right to Buy) | D | 3.97 | 10,000 | 10,000 | |||||
| 2021-06-28 | 2021-06-24 | 4 | Mendelsohn Michael | CYCN | Stock Option (Right to Buy) | D | 3.97 | 10,000 | 10,000 | |||||
| 2021-06-28 | 2021-06-24 | 4 | CONRADES GEORGE H | CYCN | Stock Option (Right to Buy) | D | 3.97 | 10,000 | 10,000 | |||||
| 2021-06-28 | 2021-06-24 | 4 | DESOUZA ERROL B | CYCN | Stock Option (Right to Buy) | D | 3.97 | 10,000 | 10,000 | |||||
| 2021-06-28 | 2021-06-24 | 4 | MCGUIRE TERRANCE | CYCN | Stock Option (Right to Buy) | D | 3.97 | 10,000 | 10,000 | |||||
| 2021-06-07 | 2021-06-03 | 4 | MCGUIRE TERRANCE By Polaris Entrepreneurs' Fund VIII, L.P. | CYCN | Common Stock | I | 3.1200 | 3,322 | 10 | 24,957 | ||||
| 2021-06-07 | 2021-06-03 | 4 | MCGUIRE TERRANCE By Polaris Partners VIII, L.P. | CYCN | Common Stock | I | 3.1200 | 92,831 | 290 | 697,313 | ||||
| 2021-06-07 | 2021-06-03 | 4 | Hecht Peter M | CYCN | Common Stock | D | 3.2800 | 823,170 | 2,700 | 2,047,698 | ||||
| 2021-06-07 | 2021-06-03 | 4 | Slate Path Capital LP | CYCN | Common Stock, no par value | I | 3.1200 | 961,538 | 3,000 | 7,157,601 | ||||
| 2021-05-19 | 3 | DESOUZA ERROL B | CYCN | Common Stock | D | 0 | ||||||||
| 2021-05-10 | 2021-05-06 | 4 | Hecht Peter M | CYCN | Common Stock | D | 2.4300 | 302,000 | 734 | 1,224,528 | ||||
| 2021-05-06 | 2021-05-05 | 4 | Hecht Peter M | CYCN | Common Stock | D | 2.5300 | 398,001 | 1,007 | 922,528 | ||||
| 2021-05-06 | 2021-05-04 | 4 | Hecht Peter M | CYCN | Common Stock | D | 2.2900 | 300,000 | 687 | 524,527 | ||||
| 2021-03-01 | 2021-02-25 | 4 | Gjino Anjeza | CYCN | Common Stock | D | 4.0000 | -1,824 | -7 | 31,599 | ||||
| 2021-03-01 | 2021-02-25 | 4 | Wright Christopher I | CYCN | Common Stock | D | 3.9900 | -2,637 | -11 | 42,728 | ||||
| 2021-01-11 | 3 | Gjino Anjeza | CYCN | Common Stock | D | 15,224 | ||||||||
| 2021-01-11 | 3 | Gjino Anjeza | CYCN | Common Stock | D | 18,199 | ||||||||
| 2021-01-11 | 3 | Gault Cheryl | CYCN | Common Stock | D | 8,500 | ||||||||
| 2021-01-11 | 3 | Gault Cheryl | CYCN | Common Stock | D | 794 | ||||||||
| 2020-12-30 | 3 | Wright Christopher I | [CYCN] | Common Stock | D | 17,009 | ||||||||
| 2020-12-30 | 3 | Wright Christopher I | [CYCN] | Common Stock | D | 28,356 | ||||||||
| 2020-12-30 | 2020-12-28 | 4 | Currie Mark G | CYCN | Common Stock | D | 3.0100 | -20,107 | -61 | 251,648 | ||||
| 2020-11-12 | 2020-11-09 | 4 | Busch Andreas | CYCN | Common Stock | D | 2.5300 | 125,000 | 316 | 254,704 | ||||
| 2020-11-10 | 2020-11-06 | 4 | Huyett William | CYCN | Common Stock | D | 2.5200 | -3,827 | -10 | 67,590 | ||||
| 2020-11-06 | 2020-11-04 | 4 | Busch Andreas | CYCN | Employee Stock Option (Right to Buy) | D | 2.48 | 75,000 | 75,000 | |||||
| 2020-08-10 | 3 | Greenspan David Gerald | CYCN | Common Stock, no par value | I | 12,392,126 | ||||||||
| 2020-08-10 | 3 | Greenspan David Gerald | CYCN | Common Stock, no par value | I | 12,392,126 | ||||||||
| 2020-08-10 | 3 | Greenspan David Gerald | CYCN | Common Stock, no par value | I | 12,392,126 | ||||||||
| 2020-08-10 | 3 | Greenspan David Gerald | CYCN | Common Stock, no par value | I | 12,392,126 | ||||||||
| 2020-06-18 | 2020-06-16 | 4 | SCHULMAN AMY W | CYCN | Stock Option (Right to Buy) | D | 4.46 | 10,000 | 10,000 | |||||
| 2020-06-18 | 2020-06-16 | 4 | Mendelsohn Michael | CYCN | Stock Option (Right to Buy) | D | 4.46 | 10,000 | 10,000 | |||||
| 2020-06-18 | 2020-06-16 | 4 | MCGUIRE TERRANCE | CYCN | Stock Option (Right to Buy) | D | 4.46 | 10,000 | 10,000 | |||||
| 2020-06-18 | 2020-06-16 | 4 | Lovell Stephanie | CYCN | Stock Option (Right to Buy) | D | 4.46 | 10,000 | 10,000 | |||||
| 2020-06-18 | 2020-06-16 | 4 | Isacson Ole | CYCN | Stock Option (Right to Buy) | D | 4.46 | 10,000 | 10,000 | |||||
| 2020-06-18 | 2020-06-16 | 4 | Fanucci Marsha | CYCN | Stock Option (Right to Buy) | D | 4.46 | 10,000 | 10,000 | |||||
| 2020-06-18 | 2020-06-16 | 4 | CONRADES GEORGE H | CYCN | Stock Option (Right to Buy) | D | 4.46 | 10,000 | 10,000 | |||||
| 2020-06-18 | 2020-06-16 | 4 | Churchwell Kevin | CYCN | Stock Option (Right to Buy) | D | 4.46 | 10,000 | 10,000 | |||||
| 2020-04-02 | 2020-03-31 | 4 | Hecht Peter M | CYCN | Employee Stock Option (Right to Buy) | D | 2.65 | 2.6500 | 153,846 | 408 | 153,846 | |||
| 2020-02-25 | 2020-02-21 | 4 | Huyett William | CYCN | Common Stock | D | 5.1200 | -3,559 | -18 | 71,417 | ||||
| 2019-12-31 | 2019-12-30 | 4 | Currie Mark G | CYCN | Common Stock | D | 2.4800 | -25,000 | -62 | 271,755 | ||||
| 2019-12-31 | 2019-12-27 | 4 | Currie Mark G | CYCN | Common Stock | D | 2.5500 | -25,000 | -64 | 296,755 | ||||
| 2019-11-26 | 2019-11-22 | 4 | Busch Andreas | CYCN | Employee Stock Option (Right to Buy) | D | 2.01 | 75,000 | 75,000 | |||||
| 2019-11-26 | 2019-11-22 | 4 | Huyett William | CYCN | Employee Stock Option (Right to Buy) | D | 2.01 | 75,000 | 75,000 | |||||
| 2019-11-26 | 2019-11-22 | 4 | Currie Mark G | CYCN | Employee Stock Option (Right to Buy) | D | 2.01 | 75,000 | 75,000 | |||||
| 2019-11-26 | 2019-11-22 | 4 | Hecht Peter M | CYCN | Employee Stock Option (Right to Buy) | D | 2.01 | 75,000 | 75,000 | |||||
| 2019-11-19 | 2019-11-15 | 4 | Busch Andreas | CYCN | Common Stock | D | 1.8200 | 125,000 | 228 | 125,000 | ||||
| 2019-11-12 | 2019-11-08 | 4 | Huyett William | CYCN | Common Stock | D | 2.0500 | -3,922 | -8 | 74,976 | ||||
| 2019-09-20 | 2019-04-01 | 4/A | Huyett William | CYCN | Employee Stock Option (Right to Buy) | D | 14.21 | 221,964 | 221,964 | |||||
| 2019-09-20 | 2019-04-01 | 4/A | Huyett William | CYCN | Employee Stock Option (Right to Buy) | D | 16.82 | 221,312 | 221,312 | |||||
| 2019-09-20 | 2019-04-01 | 4/A | Huyett William | CYCN | Common Stock | D | 39,172 | 78,898 | ||||||
| 2019-09-20 | 2019-04-01 | 4/A | Huyett William | CYCN | Common Stock | D | 38,320 | 38,320 | ||||||
| 2019-09-20 | 2019-04-01 | 4/A | Currie Mark G | CYCN | Employee Stock Option (Right to Buy) | D | 14.21 | 514,698 | 514,698 | |||||
| 2019-09-20 | 2019-04-01 | 4/A | Currie Mark G | CYCN | Employee Stock Option (Right to Buy) | D | 16.02 | 140,984 | 140,984 | |||||
| 2019-09-20 | 2019-04-01 | 4/A | Currie Mark G | CYCN | Employee Stock Option (Right to Buy) | D | 18.47 | 113,413 | 113,413 | |||||
| 2019-09-20 | 2019-04-01 | 4/A | Currie Mark G | CYCN | Employee Stock Option (Right to Buy) | D | 11.28 | 50,794 | 50,794 | |||||
| 2019-09-20 | 2019-04-01 | 4/A | Currie Mark G | CYCN | Employee Stock Option (Right to Buy) | D | 17.20 | 2,500 | 2,500 | |||||
| 2019-09-20 | 2019-04-01 | 4/A | Currie Mark G | CYCN | Employee Stock Option (Right to Buy) | D | 14.40 | 27,772 | 27,772 | |||||
| 2019-09-20 | 2019-04-01 | 4/A | Currie Mark G | CYCN | Employee Stock Option (Right to Buy) | D | 16.21 | 17,490 | 17,490 | |||||
| 2019-09-20 | 2019-04-01 | 4/A | Currie Mark G | CYCN | Employee Stock Option (Right to Buy) | D | 12.24 | 37,279 | 37,279 | |||||
| 2019-09-20 | 2019-04-01 | 4/A | Hecht Peter M | CYCN | Employee Stock Option (Right to Buy) | D | 14.21 | 857,830 | 857,830 | |||||
| 2019-09-20 | 2019-04-01 | 4/A | Hecht Peter M | CYCN | Employee Stock Option (Right to Buy) | D | 16.02 | 380,330 | 380,330 | |||||
| 2019-09-20 | 2019-04-01 | 4/A | Hecht Peter M | CYCN | Employee Stock Option (Right to Buy) | D | 18.47 | 344,777 | 344,777 | |||||
| 2019-09-20 | 2019-04-01 | 4/A | Hecht Peter M | CYCN | Employee Stock Option (Right to Buy) | D | 11.28 | 223,893 | 223,893 | |||||
| 2019-09-20 | 2019-04-01 | 4/A | Hecht Peter M | CYCN | Employee Stock Option (Right to Buy) | D | 15.54 | 37,972 | 37,972 | |||||
| 2019-09-20 | 2019-04-01 | 4/A | Hecht Peter M | CYCN | Employee Stock Option (Right to Buy) | D | 14.40 | 43,679 | 43,679 | |||||
| 2019-09-20 | 2019-04-01 | 4/A | Hecht Peter M | CYCN | Employee Stock Option (Right to Buy) | D | 16.21 | 36,088 | 36,088 | |||||
| 2019-09-20 | 2019-04-01 | 4/A | Hecht Peter M | CYCN | Employee Stock Option (Right to Buy) | D | 12.24 | 53,083 | 53,083 | |||||
| 2019-09-20 | 2019-04-01 | 4/A | Hecht Peter M | CYCN | Common Stock | D | 221,736 | 221,736 | ||||||
| 2019-07-12 | 2019-07-10 | 4 | Hecht Peter M | CYCN | Employee Stock Option (Right to Buy) | D | 6.04 | -2,000 | 0 | |||||
| 2019-07-12 | 2019-07-10 | 4 | Hecht Peter M | CYCN | Common Stock | D | 6.0400 | 2,000 | 12 | 225,192 | ||||
| 2019-06-04 | 2019-06-01 | 4 | Churchwell Kevin | CYCN | Stock Option (Right to Buy) | D | 13.95 | 10,000 | 10,000 | |||||
| 2019-06-04 | 2019-06-01 | 4 | CONRADES GEORGE H | CYCN | Stock Option (Right to Buy) | D | 13.95 | 10,000 | 10,000 | |||||
| 2019-06-04 | 2019-06-01 | 4 | Fanucci Marsha | CYCN | Stock Option (Right to Buy) | D | 13.95 | 10,000 | 10,000 | |||||
| 2019-06-04 | 2019-06-01 | 4 | Isacson Ole | CYCN | Stock Option (Right to Buy) | D | 13.95 | 10,000 | 10,000 | |||||
| 2019-06-04 | 2019-06-01 | 4 | Lovell Stephanie | CYCN | Stock Option (Right to Buy) | D | 13.95 | 10,000 | 10,000 | |||||
| 2019-06-04 | 2019-06-01 | 4 | MCGUIRE TERRANCE | CYCN | Stock Option (Right to Buy) | D | 13.95 | 10,000 | 10,000 | |||||
| 2019-06-04 | 2019-06-01 | 4 | Mendelsohn Michael | CYCN | Stock Option (Right to Buy) | D | 13.95 | 10,000 | 10,000 | |||||
| 2019-06-04 | 2019-06-01 | 4 | SCHULMAN AMY W | CYCN | Stock Option (Right to Buy) | D | 13.95 | 10,000 | 10,000 | |||||
| 2019-05-01 | 2019-04-29 | 4 | Busch Andreas | CYCN | Employee Stock Option (Right to Buy) | D | 15.40 | 300,000 | 300,000 | |||||
| 2019-04-10 | 2019-04-08 | 4 | SCHULMAN AMY W By Polaris Entrepreneurs' Fund VIII, L.P. | CYCN | Common Stock | I | 16.0000 | 21,635 | 346 | 21,635 | ||||
| 2019-04-10 | 2019-04-08 | 4 | SCHULMAN AMY W By Polaris Partners VIII, L.P. | CYCN | Common Stock | I | 16.0000 | 604,482 | 9,672 | 604,482 | ||||
| 2019-04-10 | 2019-04-08 | 4 | MCGUIRE TERRANCE By Polaris Entrepreneurs' Fund VIII, L.P. | CYCN | Common Stock | I | 16.0000 | 21,635 | 346 | 21,635 | ||||
| 2019-04-10 | 2019-04-08 | 4 | MCGUIRE TERRANCE By Polaris Partners VIII, L.P. | CYCN | Common Stock | I | 16.0000 | 604,482 | 9,672 | 604,482 | ||||
| 2019-04-04 | 2019-04-01 | 4/A | CONRADES GEORGE H | CYCN | Common Stock | D | 2,421 | 4,334 | ||||||
| 2019-04-03 | 2019-04-01 | 4/A | Fanucci Marsha | CYCN | Common Stock | D | 3,279 | 16,950 | ||||||
| 2019-04-03 | 2019-04-01 | 4/A | Fanucci Marsha | CYCN | Common Stock | D | 13,671 | 13,671 | ||||||
| 2019-04-03 | 2019-04-01 | 4 | MCGUIRE TERRANCE By Bartlett Partners, L.L.C. | CYCN | Common Stock | I | 6,911 | 6,911 | ||||||
| 2019-04-03 | 2019-04-01 | 4 | MCGUIRE TERRANCE By Polaris Venture Management Co. II, L.L.C. | CYCN | Common Stock | I | 162 | 162 | ||||||
| 2019-04-03 | 2019-04-01 | 4 | MCGUIRE TERRANCE | CYCN | Common Stock | D | 3,279 | 3,279 | ||||||
| 2019-04-03 | 2019-04-01 | 4 | MCGUIRE TERRANCE | CYCN | Common Stock | D | 7,768 | 7,768 | ||||||
| 2019-04-03 | 2019-04-01 | 4 | Hecht Peter M | CYCN | Employee Stock Option (Right to Buy) | D | 14.20 | 857,977 | 857,977 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Hecht Peter M | CYCN | Employee Stock Option (Right to Buy) | D | 16.02 | 380,393 | 380,393 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Hecht Peter M | CYCN | Employee Stock Option (Right to Buy) | D | 18.46 | 344,829 | 344,829 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Hecht Peter M | CYCN | Employee Stock Option (Right to Buy) | D | 11.28 | 223,919 | 223,919 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Hecht Peter M | CYCN | Employee Stock Option (Right to Buy) | D | 17.20 | 56,500 | 56,500 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Hecht Peter M | CYCN | Employee Stock Option (Right to Buy) | D | 15.54 | 37,973 | 37,973 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Hecht Peter M | CYCN | Employee Stock Option (Right to Buy) | D | 14.40 | 43,680 | 43,680 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Hecht Peter M | CYCN | Employee Stock Option (Right to Buy) | D | 16.21 | 36,089 | 36,089 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Hecht Peter M | CYCN | Employee Stock Option (Right to Buy) | D | 12.23 | 53,090 | 53,090 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Hecht Peter M | CYCN | Employee Stock Option (Right to Buy) | D | 12.39 | 12,499 | 12,499 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Hecht Peter M | CYCN | Employee Stock Option (Right to Buy) | D | 6.04 | 2,000 | 2,000 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Hecht Peter M The 2000 Trust for Zoe Niovi Hecht | CYCN | Common Stock | I | 485 | 485 | ||||||
| 2019-04-03 | 2019-04-01 | 4 | Hecht Peter M The 2000 Trust for Malcolm Paul Hecht | CYCN | Common Stock | I | 485 | 485 | ||||||
| 2019-04-03 | 2019-04-01 | 4 | Hecht Peter M The 2000 Trust for Alexis Mae Hecht | CYCN | Common Stock | I | 485 | 485 | ||||||
| 2019-04-03 | 2019-04-01 | 4 | Hecht Peter M | CYCN | Common Stock | D | 223,192 | 223,192 | ||||||
| 2019-04-03 | 2019-04-01 | 4 | SCHULMAN AMY W | CYCN | Common Stock | D | 3,279 | 7,508 | ||||||
| 2019-04-03 | 2019-04-01 | 4 | SCHULMAN AMY W | CYCN | Common Stock | D | 4,229 | 4,229 | ||||||
| 2019-04-03 | 2019-04-01 | 4 | Huyett William | CYCN | Employee Stock Option (Right to Buy) | D | 14.20 | 222,002 | 222,002 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Huyett William | CYCN | Employee Stock Option (Right to Buy) | D | 16.81 | 221,349 | 221,349 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Huyett William | CYCN | Common Stock | D | 39,179 | 78,912 | ||||||
| 2019-04-03 | 2019-04-01 | 4 | Huyett William | CYCN | Common Stock | D | 38,327 | 38,327 | ||||||
| 2019-04-03 | 2019-04-02 | 4 | Currie Mark G | CYCN | Common Stock | D | 14.8100 | 270,107 | 4,000 | 321,755 | ||||
| 2019-04-03 | 2019-04-01 | 4 | Currie Mark G | CYCN | Employee Stock Option (Right to Buy) | D | 14.20 | 514,786 | 514,786 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Currie Mark G | CYCN | Employee Stock Option (Right to Buy) | D | 16.02 | 141,007 | 141,007 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Currie Mark G | CYCN | Employee Stock Option (Right to Buy) | D | 18.46 | 113,430 | 113,430 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Currie Mark G | CYCN | Employee Stock Option (Right to Buy) | D | 11.28 | 50,801 | 50,801 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Currie Mark G | CYCN | Employee Stock Option (Right to Buy) | D | 17.20 | 2,500 | 2,500 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Currie Mark G | CYCN | Employee Stock Option (Right to Buy) | D | 17.20 | 13,125 | 13,125 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Currie Mark G | CYCN | Employee Stock Option (Right to Buy) | D | 15.54 | 9,930 | 9,930 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Currie Mark G | CYCN | Employee Stock Option (Right to Buy) | D | 14.40 | 27,773 | 27,773 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Currie Mark G | CYCN | Employee Stock Option (Right to Buy) | D | 16.21 | 17,491 | 17,491 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Currie Mark G | CYCN | Employee Stock Option (Right to Buy) | D | 12.23 | 37,286 | 37,286 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Currie Mark G | CYCN | Employee Stock Option (Right to Buy) | D | 12.39 | 888 | 888 | |||||
| 2019-04-03 | 2019-04-01 | 4 | Currie Mark G | CYCN | Common Stock | D | 51,648 | 51,648 | ||||||
| 2019-04-03 | 2019-04-01 | 4 | Lovell Stephanie | CYCN | Common Stock | D | 2,421 | 2,421 | ||||||
| 2019-04-03 | 2019-04-01 | 4 | Mendelsohn Michael | CYCN | Common Stock | D | 2,421 | 2,421 | ||||||
| 2019-04-03 | 2019-04-01 | 4 | Fanucci Marsha | CYCN | Common Stock | D | 3,279 | 16,950 | ||||||
| 2019-04-03 | 2019-04-01 | 4 | Fanucci Marsha | CYCN | Common Stock | D | 13,671 | 13,671 | ||||||
| 2019-04-03 | 2019-04-01 | 4 | Isacson Ole | CYCN | Common Stock | D | 2,421 | 2,421 | ||||||
| 2019-04-03 | 2019-04-01 | 4 | CONRADES GEORGE H | CYCN | Common Stock | D | 2,421 | 2,421 | ||||||
| 2019-04-03 | 2019-04-01 | 4 | Churchwell Kevin | CYCN | Common Stock | D | 2,421 | 2,421 | ||||||
| 2019-04-02 | 2019-04-01 | 4 | IRONWOOD PHARMACEUTICALS INC | CYCN | Common Stock | D | -15,562,555 | 0 | ||||||
| 2019-04-02 | 2019-03-29 | 4 | IRONWOOD PHARMACEUTICALS INC | CYCN | Common Stock | D | 15,562,455 | 15,562,555 | ||||||
| 2019-03-14 | 3 | IRONWOOD PHARMACEUTICALS INC | CYCN | Common Stock | D | 200 | ||||||||
| 2019-03-14 | 3 | IRONWOOD PHARMACEUTICALS INC | CYCN | Common Stock | D | 200 | ||||||||
| 2019-03-14 | 3 | IRONWOOD PHARMACEUTICALS INC | CYCN | Common Stock | D | 200 |
P
Pembelian sekuritas non-derivatif atau derivatif di pasar terbuka atau secara pribadi.
S
Penjualan terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif.
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi turunan
D
Penjualan atau pengalihan sekuritas kembali ke perusahaan.
F
Pembayaran harga pelaksanaan atau kewajiban pajak menggunakan sebagian sekuritas yang diterima dari perusahaan.
G
Pemberian sekuritas oleh atau kepada orang dalam.
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Pelaksanaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Transaksi yang dilaporkan secara sukarela pada Formulir 4.
J
Lainnya (disertai dengan catatan kaki yang menjelaskan transaksi tersebut)
